Navigation Links
Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
Date:12/11/2007

the European Union prior to the end of the year or at all, and any marketing approval, if granted, may have significant limitations on its use. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements.

These and other risks are described in detail in the Gilead's Annual Report on Form 10-K for the year ended December 31, 2006 and its Quarterly Reports on Form 10-Q for the first three quarters of 2007, filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead and Gilead assumes no obligation to update any such forward-looking statements.
Full U.S. prescribing information, including Boxed WARNINGS, for ATRIPLA is

available at http://www.atripla.com. Full U.S. prescribing information for SUSTIVA is available at http://www.bms.com. Full U.S. prescribing information for Truvada, Viread and Emtriva, including

Boxed WARNINGS, are available at http://www.gilead.com. EU Summary of Product Characteristics for Truvada, Viread, Emtriva, SUSTIVA and STOCRIN are available at http://www.emea.europa.eu/htms/human/epar/a.htm.
ATRIPLA is a registered trademark of Bristol-Myers Squibb & Gilead Sciences,

LLC. SUSTIVA is a registered trademark of Bristol-Myers Squibb Pharma Company.

STOCRIN is a registered trademark of Merck & Co., Inc. Truvada, Viread and Emtriva are all registered trademarks of Gilead Sciences,

Inc.


'/>"/>
SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
2. Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
3. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
4. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
7. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
8. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
11. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21, 2015  Inmark,s acquisition of Saf-T-Pak last ... Goods Training, specifically Division 6.2.  For over 25 ... training programs focusing on IATA, ICAO, US DOT, ... "We were particularly interested in Saf-T-Pak,s ... multilingual internet training programs," said David Oyler ...
(Date:4/21/2015)... 21, 2015 Global cap & ... demand for caps and closures will exceed $55 billion in ... two trillion annually. Beverages will continue to account for well ... a number of smaller markets are expected to register faster ... Although the most developed markets -- the US, ...
(Date:4/21/2015)... 21, 2015 The global dermatology diagnostic devices ... 8.2% from 2014 to 2019. North America ... larger shares in the global dermatology diagnostic devices market. ... is mainly attributed to a wide range of factors, ... of dermatologists, and technological advancements made in the field ...
Breaking Medicine Technology:Inmark's Acquisition Of Saf-T-Pak Results In Expansion Of Its Dangerous Goods Training Portfolio 2World Caps & Closures Market 2World Caps & Closures Market 3Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 2Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 3
(Date:4/21/2015)... April 21, 2015 The California ... 275 leading life sciences organizations, released the following ... regarding California State Assembly Bill (AB) 463: , ... to the development of treatments and cures for ... deep concerns regarding AB 463, the so-called Pharmaceutical ...
(Date:4/21/2015)... NJ (PRWEB) April 21, 2015 ... across platforms and devices, today announced a new enhancement ... of the new Microsoft Office 365 Management Activity API. ... customers to fully audit and take action on all ... , “The new Office 365 Management Activity API provides ...
(Date:4/21/2015)... released a new blog post explaining how to find ... are large vehicles that fare well in crash tests. A ... car shows that passengers from the first car have a ... but these large vehicles may be unstable and they may ... possible to find low cost car insurance plans on a ...
(Date:4/21/2015)... Carinsurancehints.com has released a new blog post presenting heavily ... auto insurance prices . , Commuting on heavy ... review their insurance options before deciding what plan to ... Some of the popular policies provide liability, collision or ... and find the best prices in their area simply ...
(Date:4/21/2015)... Respected academic institution selects Visage 7 for ... Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro ... contract with University of Florida Health — a large ... furthers the penetration of Visage 7 technology ... the North American enterprise imaging market. Visage 7 ...
Breaking Medicine News(10 mins):Health News:California Healthcare Institute Statement on AB 463 2Health News:California Healthcare Institute Statement on AB 463 3Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 2Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 3Health News:Auto Insurance Quotes For SUVs Are Available Online 2Health News:Heavily Circulated Roads Can increase Auto Insurance Costs 2Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4
... , The New Pharmacy Benefit Evaluator Analyzes Health Plan ... Inform Managed Care Sales Strategy Development , , ... of managed care market intelligence, has enhanced its ... that analyzes health plan pharmacy benefit structure and spending ...
... campaign finance watchdog group , , WASHINGTON, ... million to influence Congress and Administrations over the last ten ... last two decades, according to a Public Campaign Action Fund ... , , "When President Obama addresses the AMA today, ...
... Sciences Centre (LHSC) working in collaboration with researchers at ... has joined 16 other world-class centres to form HEARRING ... of Excellence. These centres, which are leaders within ... "cluster". This will allow members to set scientific and ...
... anti-inflammatory drugs might protect people struggling with dementia from ... release of a study of human brain tissue in ... Brain Institute of the University of Florida, in collaboration ... that inflammation of microglia an abundant cell type ...
... Sixty-four survivors of medical malpractice from 21 states sent ... the rights of medical malpractice victims have become a "political ... care plan, and that their rights may be stripped away ... supports measures that would drastically limit injured patients, rights to ...
... Six of the world,s foremost health agencies, collectively ... research funding, today announced formation of a landmark ... chronic, non-communicable diseases: cardiovascular diseases (mainly heart disease ... type 2 diabetes. , The health impact ...
Cached Medicine News:Health News:HealthLeaders-InterStudy Launches Pharmacy Benefit Evaluator 2Health News:Backgrounder: As Obama Makes Pitch to AMA, the Group Tries to Call in its Political Investment in Congress 2Health News:Popular Alzheimer's theory may be false trail 2Health News:Popular Alzheimer's theory may be false trail 3Health News:Medical Malpractice Survivors Decry Possible Stripping of Rights in President's Health Care Plan 2Health News:Health research agencies form global alliance to curb humanity's most fatal diseases 2
Easy to use practice management software....
... Practice Management software- ... system of Software, Support, ... offices of Optometry, Ophthalmology, ... streamlines office operations, allowing ...
... hematology system delivers a full ... for speed and accuracy, this ... with impressive productivity. The Advia ... its own or twinned with ...
The XT-1800i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...
Medicine Products: